In August 2026, the Hershey Company board found itself in the crosshairs of a hostile takeover bid from Mondelez International. This episode of Boardroom Conversations with Fexingo dissects the board's playbook: the poison pill, the appeal to Pennsylvania's attorney general, and the delicate balance between shareholder value and a century-old corporate mission. We break down the board's fiduciary duty, the role of the Hershey Trust, and why a 3.5 percent dividend yield wasn't enough to satisfy activist investors. Lucas and Luna walk through the timeline, the board's rejection letter, and the strategic defense that kept Hershey independent — at least for now. If you've ever wondered how boards fight off unsolicited offers without tanking their stock, this episode gives you the concrete mechanics, from the 'just say no' defense to the state attorney general's unlikely intervention. Tune in for a masterclass in corporate defense, and learn what it really takes to protect a company's legacy in the face of billions.